Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-01-10 @ 2:08 PM
Study NCT ID:
NCT02516605
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2015-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-04
First Submit QC Date:
None
Study First Post Date:
2015-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-01
Results First Submit QC Date:
None
Results First Post Date:
2019-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-09
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL